Abstract:Biodegradable polymer-based therapeutics have recently become essential drug delivery biomaterials for various bioactive compounds. Biodegradable and biocompatible polymer-based biomaterials fulfill the requirements of these therapeutics because they enable to obtain polymer biomaterials with optimized blood circulation, pharmacokinetics, biodegradability, and renal excretion. Herein, we describe an adaptable polymerization platform employed for the synthesis of long-circulating, stimulus-sensitive and biodegradable biomaterials, therapeutics, or theranostics. Four chain transfer agents (CTA) were designed and successfully synthesized for the reversible addition-fragmentation chain transfer polymerization, allowing the straightforward synthesis of hydrolytically biodegradable structures of block copolymers-based biomaterials. The controlled polymerization using the CTAs enables controlling the half-life of the hydrolytic degradation of polymer precursors in a wide range from 5 h to 21 days. Moreover, the antitumor drug pirarubicin (THP) was successfully conjugated to the polymer biomaterials via a pH-sensitive hydrazone bond for in vitro and in vivo experiments. Polymer conjugates demonstrated superior antitumor efficacy compared to basic linear polymer-based conjugates. Notably, the biodegradable systems, even though those with degradation in the order of hours were selected, increased the half-life of THP in the bloodstream almost two-fold. Indeed, the presented platform design enables the main chain-end specific attachment of targeting ligands or diagnostic molecules. The adaptable polymerization platform design allows tuning of the biodegradability rate, stimuli-sensitive drug bonding, and optimized pharmacokinetics to increase the therapy outcome and system targeting, thus allowing the preparation of targeted or theranostic polymer conjugates. STATEMENT OF SIGNIFICANCE: Biodegradable and biocompatible polymer-based biomaterials are recognized as potential future bioactive nanomedicines. To advance the development of such biomaterials, we developed polymerization platforms utilizing tailored chain transfer agents allowing the straightforward synthesis of hydrolytically degradable polymer biomaterials with tuned biodegradability from hours to several days. The platform allows for the synthesis of long-circulating, stimulus-sensitive and biodegradable biomaterial serving as drug carriers or theranostics. The therapeutic potential was validated by preparation of polymer biomaterials containing pirarubicin, anticancer drug, bound via pH sensitive bond and by showing prolonged blood circulation and increased antitumor activity while keeping the drug side effects low. This work paves the way for future development of biodegradable polymer biomaterials with advanced properties in drug delivery.

Parenteral depot-systems on the basis of biodegradable polyesters

Modulating Drug Release from Short Poly(ethylene Glycol) Block Initiated Poly(L-lactide) Di-block Copolymers

Adaptable polymerization platform for therapeutics with tunable biodegradability

Cytocompatibility Evaluation of a Novel Series of PEG-Functionalized Lactide-Caprolactone Copolymer Biomaterials for Cardiovascular Applications

Preparation, Characterization and Degradation Characteristics of Polyanhydrides Containing Poly(Ethylene Glycol)

PEGylated polylactide (PLA) and poly (lactic-co-glycolic acid) (PLGA) copolymers for the design of drug delivery systems

Injectable controlled release depots for large molecules

Comparison of the properties of implantable matrices prepared from degradable and non-degradable polymers for bisphosphonate delivery

Biodegradable Polymers for Microencapsulation Systems

In Vitro and in Vivo Degradation Study on Novel Blends Composed of Polyphosphazene and Polyester or Polyanhydride

Novel Blends of Poly[Bis(Glycine Ethyl Ester) Phosphazene] and Polyesters or Polyanhydrides: Compatibility and Degradation Characteristics in Vitro

Latest Research Progress of Drug Stability and Release of PLGA Microspheres

Controlled release of goserelin from microporous polyglycolide and polylactide

Poly(lactic acid)/poly(lactic-co-glycolic acid)-based microparticles: an overview

Biodegradable injectable polyurethanes: synthesis and evaluation for orthopaedic applications

Preparation of PLGA Microspheres Using the Non-Toxic Glycofurol as Polymer Solvent by a Modified Phase Inversion Methodology

Extended Release of Native Drug Conjugated in Polyketal Microparticles

Thermogelling, ABC Triblock Copolymer Platform for Resorbable Hydrogels with Tunable, Degradation-Mediated Drug Release

Biodegradable dexamethasone polymer capsule for long-term release

Design of a core-shelled polymer cylinder for potential programmable drug delivery

Compatibility and degradation of novel polyphosphazene/polyanhydride blends